REGN vs ST · P/E 14, rev $14.34B vs P/E 150, rev $3.93B
Regeneron Pharmaceuticals Inc (REGN) versus Sensata Technologies Holding NV (ST) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Sensata Technologies Holding NV (ST) is a scientific & technical instruments company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported ST revenue for 2024-12-31 was $3.93B. Net income was $128.5M. Revenue was down 3.0% from 2023-12-31 to 2024-12-31. ST currently screens at market cap $7.19B and trailing P/E 149.9.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. ST currently screens at market cap $7.19B and trailing P/E 149.9.
Not investment advice. Open the REGN and ST stock pages for the full models.
Not investment advice.